DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

25.05 -0.17 (-0.67%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLDX $25.05 -0.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $25.78
Previous Close $25.22
Daily Range $24.55 - $25.78
52-Week Range $11.93 - $32.82
Market Cap $2.5B
P/E Ratio -19.11
Dividend (Yield) $0.00 (0.0%)
Volume 995,029
Average Daily Volume 1,293,945
Current FY EPS -$1.40

Sector

Healthcare

Industry

Drug Makers

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website: http://www.celldex.com/

News & Commentary

Making Big Bucks with Biotech: Why the P-Test is Key

Understand the connection between statistics and biotech stocks.

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

These 3 Biotech Stocks Are Losing Money, But We'd Still Buy Them

Nearly 90% of biotech stocks are losing money, but that doesn't mean our healthcare analysts don't perceive there to be value in the sector.

This Terrifying Cancer May Finally Be Treatable

Celldex Therapeutics reported some highly encouraging data for its experimental brain cancer vaccine Rintega at the recent ASCO meeting. Could this vaccine prove to be a game-changer in the fight against this deadly disease?

Biotech Stock Mailbag: More Duchenne Drama, CAR-T Trouble, ASCO '15 Rewind

Celldex Glioblastoma Vaccine Hits Phase II Primary Endpoint - Analyst Blog

Celldex Glioblastoma Vaccine Hits Phase II Primary Endpoint - Analyst Blog

Cantor Fitzgerald and Brean Capital Positive on Celldex Therapeutics Following Positive Data ...

Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG ...

Morning Market Losers

See More CLDX News...

CLDX's Top Competitors

CLDX $25.05 (-0.67%)
Current stock: CLDX
AMGN $154.99 (0.96%)
Current stock: AMGN
GILD $116.01 (-0.91%)
Current stock: GILD
BIIB $405.41 (0.36%)
Current stock: BIIB